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The aim of  this study was to determine whether synovial fl uid (SF) of  dogs contains 
cells that have characteristics of  MSCs and to describe their differentiation potential. 
SF adherent cells from 5 young German shepherd dogs (average 3.8 ± 0.9 years) were 
expanded (37ºC, 5% CO2, humidifi ed atmosphere) three weeks before their phenotype 
was characterized by fl ow-cytometry for the presence of  CD90 and CD34. Population 
doubling time (PDT), number of  CFU-F and adipogenic, osteogenic and chondrogenic 
potentials have been determined in vitro. In early passages PTD was 31 ± 10 hours 
and expansion fold after 3 sub cultivations (9 days) theoretically could be 372 ± 134. 
At P1, 0.55 ± 0.05% of  SF cells had the ability to form CFU-F. Sixty-six percent 
of  cells expressed CD90 and none of  the cells expressed markers of  hematopoietic 
cells. Oil Red O staining has shown accumulation of  fat droplets in cells grown in 
adipogenic medium, while deposits of  calcium in the osteogenic medium were 
evidenced with Alizarin red staining. SF cultured in hondrogenic and control medium 
in three-dimensional conditions formed a cartilage-like tissue. Alcian blue staining 
of  pellets’ slides have shown a signifi cant amount of  glycosaminoglycans (GAGs) 
and immunohistochemistry analysis documented collagen type II expression. The 
amount of  GAGs in pellets grown in both conditions showed no difference. SF cells 
in vitro exhibited osteogenic, adipogenic and chondrogenic differentiation potentials, 
suggesting the presence of  different mesenchymal progenitors. These results also 
demonstrated that SF cells have a spontaneous chondrogenic potential that should be 
further explored for possible tissue engineering protocols. 
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INTRODUCTION
Normal synovial fl uid (SF) is a hyaluronic acid rich, viscous liquid that protects 
diarthrodial joints and nourishes chondrocytes of  avascular hyaline cartilage. Its 
volume in the knee joint varies between 0.1 to 1.0 mL and depends on dog size and 
weight. Normal SF contains approximately two to three million of  cells per milliliter, 
predominantly mononuclear cells (lymphocytes, monocytes and sinoviocytes), while 
polymorphonuclear cells make up less than 10% of  the total population. The main 
function of  the SF leukocyte population is the immune surveillance of  the joint 
tissue. Their transendothelial migration is similar in all tissues [1]. On the contratry, 
mechanism of  steady state mobilization of  synovial membrane (SM) synoviocytes into 
the SF has not been investigated. Also, the function of  synoviocytes in the SF is just 
beginning to be defi ned and the fi rst data obtained in rabbits [2,3] and some very 
recent experimental data in porcine, rats and rabbits point that SF cells could directly 
differentiate into chondrocytes and meniscal cells when hyaline cartilage or meniscal 
injury is provoked [2-6].
The normal SM is a fi ne structure consisting of  a thin intimal layer of  cells without a 
basal membrane, and subintimal tissue with scarce connective tissue cells, and blood 
and lymphatic vessels [1]. The intimal layer has two types of  synoviocytes: type A 
that expresses markers of  macrophages like CD163 and CD68 and type B that are 
fi broblasts expressing CD55, adapted to produce hyaluronic acid [1]. Although in situ 
examination does not reveal frequent cell divisions, it is well know that after trauma or 
during the course of  osteoarthritis (OA) and rheumatoid arthritis (RA), proliferation 
of  synoviocytes and other cells leads to the formation of  pannus [7]. In several animal 
species and humans, multipotency and a large proliferative potential i.e. mesenchymal 
stem cell-like properties of  SM and SF synoviocytes have been described [2-6, 8-11]. 
Moreover, chondrogenic potential of  in vitro expanded SF synoviocytes has been 
proved to be more consistent than the same potential of  bone marrow MSCs [12]. 
Synovial fl uid cells could easily and repetitively be obtained without tissue trauma and 
consequent infl ammation [13] making SF cells an interesting cell population for the 
management of  cartilage repair and tissue engineering.
More than one fi fth of  dogs and two thirds of  the aged human population are 
affected with different types of  OA and consequently have cartilage injury, loss 
of  chondrocytes and degradation of  extracellular matrix i.e. collagen type II and 
glycosaminoglycans (GAGs). Hyaline cartilage has limited self-renewal potential 
and treatment options include surgery or the application of  anti-infl ammatory 
drugs and analgetics [14]. Neither of  these treatments leads to cartilage regeneration 
nor permanent improvement of  the initial damage. As described previously, some 
of  SF cells also have mesenchymal stem cell (MSC) like properties and important 
regenerative potential [2-6]. Dogs are the model recommended by the Osteoarthritis 
Research Society International (OARSI) for investigation of  OA pathogenesis [15]. 
Also, dogs are frequent patients for OA therapy. One of  the suggested therapeutic 
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modalities for OA is intra-articular application of  non-differentiated MSCs or MSCs 
primed for chondrogenesis [16]. Data on proliferation and differentiation potential of  
canine synovial fl uid cells are scarce and until present, only one article dealt with the 
chondrogenic potential of  these cells in two dogs [17]. 
The aim of  this study was to determine whether SF isolated from knee joints of  
adult young dogs without signs of  OA or infl ammation contains cells that have the 
characteristics of  MSCs, and to describe their differentiation potential. The most 
important in vitro characteristic to be determined is the cartilage forming potential 
during the process of  induced chondrogenesis.
MATERIALS AND METHODS
Synovial fl uid analyses and cell isolation
Synovial fl uid was aseptically aspirated from the knee stifl e joint from 5 young German 
shepherd dogs (average 3.8 ± 0.9 years). In order to determine the total number of  
nucleated cells (TNCC), equal volumes of  500 U/mL hyaluronidase solution (Sigma) 
and SF samples were incubated at 37°C for 30 min. TNCC was determined using 
a hemocytometer with Trypan blue in acetic acid solution. Serum amyloid A was 
determined with ELISA kit (Tridelta, Irland). 
Fresh SF samples were deposed over the whole surface in Petri dishes (10cm2) in 
DMEM (Dulbecco’s Modifi ed Eagles Medium - Invitrogen) supplemented with 10% 
FBS (MSC-Qualifi ed FBS, Gibco), 1% L-glutamine, and 1% Pen/Strep solution 
(Gibco, Life Technologies, Grand Island, NY 14072, USA). Cells were incubated at 
37°C, in a humidifi ed atmosphere containing 5% CO2 and 95% air (Binder, Germany). 
The medium was changed 24 hours after seeding to remove the non-adherent cells. 
Thereafter, the culture medium was changed every two to three days. SF cells at 
passage zero (P0) were grown to 80-90% confl uence and then detached using trypsin 
(TrypLE ™ Express, Gibco). Cells from each of  the 5 dogs were reseeded at a density 
of  5000 cells/cm2 in T-25 fl asks (BD Falcon Primaria® plastic, Biosciences) and for all 
subsequent analysis sub cultured until passage fi ve (P5).
Colony-forming unit-fi broblasts (CFU-F)
Passage one SF cells (P1) were seeded in Petri dishes (10cm2) at a density of  500 
cells/cm² in the control medium. After 7 days, cells were washed in PBS, fi xed in 
methanol 10 minutes and stained with Giemsa solution. Using an inverted microscope 
(Olympus CKX41/CKX31) aggregates with ≥ 50 cells were counted as colonies. 
Moreover, colonies larger than 1mm were counted separately than those smaller than 
1mm. The number of  CFU-F was expressed as the percentage of  cells seeded but able 
to form colonies.
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Population Doubling Time (PDT) and expansion fold
SF cells (P1-P3) were seeded in triplicate in Petri dishes (10cm2) at a density of  
1x104cells/cm2 in the control medium. Every time the cells were sub cultivated during 
3 days to obtain cells in the exponential phases of  cell growth. PDT was determined 
based on the number of  seeded cells and the number of  cells obtained after trypsin 
detachment, when the cells reached approximately 70% confl uence. Viable cells were 
counted using trypan blue. PDT was calculated according to the formula: 
PDT = [ln (Nf  / N0) / ln (2)] / t
Nf  was the cell number obtained after detachment, N0 was the seeded cell number, t 
was the cultivation period in hours. Cell expansion fold at each week of  culture was 
calculated by the number of  cultured cells divided by the number of  seeded cells. After 
cell detachment, the majority of  cells were frozen or used for other analyses and one 
part of  the cells was diluted in the new medium and re-seeded. The theoretical total 
cell expansion fold was calculated by multiplying the expansion fold for each week and 
the theoretical fi nal cell number was calculated by multiplying P1 cell number with the 
total cell expansion fold.
Phenotypic characterization of SF cells
Cells from each of  the 5 dogs (P3-P5) were characterized by fl ow-cytometry using 
mouse-anti-human CD90 FITC and mouse anti-dog CD34 PE (BD Pharmingen, 
Biosciences, San Jose, CA, USA). After detachment of  adherent cells by trypsin 
and washing in cold PBS/1% FCS solution the aliquots containing 1x106 cells were 
incubated with antibodies at 4°C for 45 minutes. After washing in PBS/1% FCS/5% 
Na-azide, cells were fi xed in 1% paraformaldehyde and analyzed by CyFlow CL 
cytometer (Partec, Münster, Germany). Results were expressed as the percentage 
of  positive cells compared with the isotype-matched negative control antibodies on 
histogram plots. 
In vitro differentiation of the SF cells
Differentiation potential of  SF cells from passage 3 to 5 (P3-P5) was investigated 
by cultivating the cells in commercial adipogenic, osteogenic and chondrogenic 
differentiation media (Stem PRO media Invitrogen, Carlsbad, CA, USA) at 37°C in a 
humidifi ed atmosphere with 5% CO2 and 95% air. For in vitro adipogenic differentiation 
cells were seeded in triplicate at a density of  5x103cells/cm2 in 8-well plates (BD Falcon 
Culture Slides) in the complete and Stem PRO adipogenesis medium. After 14 days of  
cultivation accumulation of  fat droplets in the cells was shown with Oil Red O staining 
(Sigma-Aldrich) according to the procedure described: cells were washed in PBS, fi xed 
in 10% formaldehyde and rinsed with 60% isopropanol. 3% Oil Red O solution in 
60% isopropanol was added for 10 min. Stained cells were extensively washed with 
distilled water to remove any non-specifi c staining and visualized using an inverted 
microscope (LEICA DMIL LED, Wetzlar, Germany).
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For in vitro osteogenic differentiation expanded SF cells were seeded in triplicate at a 
density of  1x104cells/cm2 in 8-well plates (BD Falcon Culture Slides) in the complete 
and Stem PRO osteogenesis medium for 21 days. Some cultures were interrupted the 
fi fth day to determine alkaline phosphatase (AP) activity using Alkaline Phosphatase 
Detection Kit (Sigma) according to manufacturer’s instructions. In order to show 
calcium deposits formed after three weeks of  cultivation, cells were washed with PBS 
and stained with 2% Alizarin Red S (Alizarin Red S, pH 4. 2, Sigma-Aldrich) solution 
for 2 min. 
In order to examine the potential for chondrogenesis expanded SF cells were cultured 
in the control and chondrogenic medium in three-dimensional conditions (3D). To 
obtain a three-dimensional cell pellet, 5x105cells were centrifuged for 5 min at 250 x g 
in 15 mL polypropylene tubes. After three weeks of  cultivation, pellets were fi xed in 
10% neutral formalin for 24 hours, dehydrated through a series of  alcohol dilutions, 
embedded in paraffi n and stained with alcian blue to examine the presence of  GAGs. 
The presence of  collagen II was determined by immunohistochemistry (IHC). 
Concentration of GAG and quantifi cation of DNA
After papain digestion of  cartilaginous pellets, GAG concentration was quantifi ed 
with the colorimetric method (Biocolor, UK, B1000) and total DNA with the 
fl uorometric assay (FluoReporter® Blue Fluorometric dsDNA Quantitation Kit, 
Invitrogen, Molecular Probes) on a spectrofl uorimeter according to manufacturer’s 
instructions (VICTOR3V 1420-040 multilabel counter, Perkin Elmer Life and Analytical 
Sciences, Singapore) and emission was measured at 460 nm. Results were expressed as μg 
GAG/μg DNA.
RESULTS
Synovial fl uid was clear and viscous with protein concentration (21.1 ± 10.8 g/L), 
TNCC (0.25 ± 0.1/mL) and volume of  SF within reference intervals (0.99 ± 0.5 mL). 
None of  the dogs included in this study had detectable SF SAA indicating no 
infl ammation.
During in vitro manipulation of  cells they were viable in a high percentage (99%). 
The average number of  cells seeded in P0 was 0.2 ± 0.05 x 106 (Table 1). Few hours 
after seeding the cells, they adopted a fi broblastoid morphology and after 5 to 7 days 
of  cultivation they were elongated with multiple processes (Figure 1). In passages 
P1 to P3 PDT was 31 ± 10 hours and expansion fold after 3 sub cultivations was 
372 ± 134 that theoretically could result in a high cell number suitable for further 
use (Table 1). At P1, 0.55 ± 0.05 % of  SF cells had the ability to form CFU-F. The 
majority of  CFU-F were large (diameter > 1mm), made of  thousands of  cells, with 
high proliferative potential (Figure 1). 
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The mean value of  CD90 (+) cells from all fi ve dogs (P3 - P5) was 56.43±10.56% and 
for CD34 (-), 0.31±0.05%. Percentage of  CD90 (+) expanded SF cells was slightly 
larger than the percentage of  CD90 (-) cells (Figure 2a). Expanded SF cells in the same 
passages were CD34 (-) (Figure 2b). Samples were homogenous regarding CD90 and 
CD34 expression.
Table 1. Number of  cells isolated from the synovial fl uid, number of  Colony Forming Unit 
-Fibroblast (CFU-F) and ratio large/small colonies has been shown as well as proliferative 
characteristics of  the seeded cells from P0 to P3 (P-passage)
P0 – TCS (x106/mL) P0 – TCH (x106/mL) P1 - CFU-F (%) [large/small]
X ± SD 0.25 ± 0.1 0.65 ± 0.05 0.5 ± 0.2   [2/1]
min - max 0.15 - 0.5 0.2 - 1.4 0.3 - 0.7
P1-P3 PDT (h) EF - 9 (days) TFCN (x106)
X ± SD 31.3 ± 9.7 372 ± 134 223
min - max 19.4 - 48.0 218 - 465 /
TCS – Total cells seeded; TCH – Total cells harvested; PDT – Population doubling time; 
EF – Expansion fold; TFCN – Theoretical fi nal cell number after 9 days of  cultivation
Figure 1. Freshly isolated synovial fl uid cell population (a). Twenty-four hours after seeding 
the initial cell population; adherent cells have become fi broblastoid (b). After 6 to 10 days of  
cultivation cells have been nearly confl uent; occasionaly Colony Forming Unites – Fibroblast 
have been formed (c). Inverted microscope, bar 200 μm.
Figure 2. Representative fl ow-cytometery histograms showing the percentage of  cells 
expressing (non-shaded) CD34 molecules (a) and CD90 molecules (b) compared with isotype 
controls (shaded).
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Figure 3. Morphology of  differentiated and control synovial fl uid cells stained with different 
techniques. Large lipid droplets in the cytoplasm of  individual cells with pre-adipocyte 
morphology, after 2 weeks in adipogenic medium, Oil red O, inverted microscope, bar 50 μm 
(a). Accumulation of  small lipid droplets in the cytoplasm of   undifferentiated cells cultivated 
in the control medium; inverted microscope, bar 50 μm (b). Alkaline phosphatase activity, fi fth 
day of  cultivation in osteogenic medium (c) and control medium, cytochemistry, bar 200 μm 
(d). Deposits of  calcium phosphate stained intensely red with Alizarin red, after three weeks 
of  cultivation in the osteogenic medium (e) no staining in the control medium, bar 500 μm 
(f). Pellets’ cartilage-like tissue stained with Alcian blue, after 3 weeks of  cultivation in the 
chondrogenic (g) or control medium, bar 200 μm (h); Note the intense blue staining of  GAG 
in the extracelullar matrix (ECM), red nucleus staining and presence of  homogeneous pink 
islands in the ECM (g and h). Collagen type II in the cartilage-like tissue after 3 weeks of  
cultivation in the chondrogenic medium (i); and control medium (j); immunohistochemistry, 
bar 200 μm. Note that the pattern of  collagen type II staining follows the pattern of  pink 
islands in Alcian blue staining in both mediums (i). k. Cartilage-like tissue after 3 weeks of  
cultivation in chondrogenic medium. Collagen type II immunostaining. Representative negative 
reaction slides. No expression in ECM. 
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The major functional characteristic of  adult MSCs is their potential to differentiate 
towards multiple lineages. After two weeks in the adipogenic medium, some of  the 
cells have lost their fi broblastoid morphology and accumulated prominent fat droplets 
(Figure 3a). In the control medium after 14 days expanded SF cells formed small 
multilocular fat droplets without signs of  change in the cell morphology (Figure 3b). 
The fi fth day of  cultivation in the osteogenic medium some of  the cells synthesized 
AP (Figure 3c) and after 3 weeks clusters of  cells formed deposits of  calcium salts 
demonstrated by Alizarin red staining (Figure 3e). Expanded SF cells cultured in the 
hondrogenic and control medium formed pellets with cartilage-like tissue. Histological 
analysis of  pellets cultivated in both, control and chondrogenic medium, stained 
with Alcian blue showing the presence of  GAGs (Figures 3g, 3h). The amount of  
GAGs was not signifi cantly higher in pellets grown in the control in comparison to 
the chondrogenic medium  (37.0 ± 8.7 μg/mL and 45.9 ± 14.3 μg/mL, respectively). 
Immunohistochemistry analysis of  pellets cultured in both conditions revealed intense 
staining of  collagen type II in ECM, in an island-like formation that resembled hyaline 
cartilage (Figure 3i, 3j). Using histology and IHH techniques no differences in the 
chondrogenic potential between individual animals were noted.
DISCUSSION
The main fi nding of  this work is that cells, cultivated from SF of  adult young dogs 
without signs of  OA or infl ammation, have a large proliferative potential and the 
possibility to differentiate toward adipocytes, osteoblasts and chondrocytes, i.e. these 
cells have typical in vitro characteristics of  mesenchymal progenitor cells. 
The minimal criteria for defi ning multi-potent mesenchymal stem/stromal cells 
were published eight years ago and basically relayed on properties that distinguish 
connective tissue cells from hematopoietic cells [18]. These include: adherence to 
plastic (hematopoietic cells are non-adherent cells that grow in suspension culture), in 
vitro tri-lineage differentiation towards adipocytes, osteoblasts and chondrocytes, and 
a phenotype that excludes non-differentiated hematopoietic cells (that are CD34+) 
and leukocytes (that are CD45+), but identifi es cells that express CD105, CD90 and 
CD73. Although many more articles refer their investigation to mesenchymal stem 
cells and not progenitor cells, one should keep in mind that true stem cells possess 
self-renewal capability that could be proved only after serial transplantation of  the 
desired cell population [19]. This type of  experiment is rarely performed. As we did 
not have the possibility to test the self-renewal capacity of  our cell population, we 
consider that we cultivated a progenitor cell population and in the following text, we 
will use the term mesenchymal progenitors.
In this experiment, canine SF cells were tested for a combination of  CD34 and 
CD90, which are frequently used markers for SF cells to screen or to distinguish the 
non-differentiated hematopoietic from the mesenchymal cell population [17]. Based 
on CD34 expression, in our culture system, non-differentiated hematopoietic cells 
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were not present. On average 56% of  expanded cells expressed CD90 and 44% did 
not. The reason for this heterogeneity was that our cultures were polyclonal and 
probably maintained themselves through divisions of  progenitor/precursor cells 
of  synoviocytes type A and/or type B, or even mature synoviocytes. Although not 
confi rmed, the synoviocytes type A are supposed to derive from blood monocytes and 
synoviocytes type B probably represent the true cells of  mesenchymal origin [1]. As it 
was described previously, blood monocytes could derive from different bone marrow 
stem/progenitor cells and differentiate to macrophages or even to fi broblastoid cells 
[20]. We could only speculate that CD90 (-) cells were derived from synoviocytes type 
A and CD90 (+) cells from synoviocytes type B. Similarly to our fi nding, culture of  SF 
adherent cells in human patients with RA had two types of  cells: fi broblastoid CD90 
(+) and macrophage-like CD90 (-) CD68 (+) [21]. Also, CD90 (+) cells have been 
described to have spontaneous chondrogenic potential in vitro [17]. All stated suggests 
that although both cell types have the ability to proliferate it would be of  great interest 
to separate both cell types from the very beginning and investigate their properties 
separately.
In our culture system the PDT was on average 31 h. This is a longer doubling time than 
we previously have obtained for dental pulp stem cells being on average 24 h [22]. This 
observation is in line with the fact that most of  SF cells are probably desquamated 
cells without high proliferative potential and with a slow cell cycle. As our culture 
system was polyclonal, the obtained PDT refl ect the mean of  doubling times of  all 
cultured cells. The possibility that among SF cells we raised the true mesenchymal 
progenitor cells is supported with the fact that on average one cell in 200 cells was 
CFU-F and the majority of  these colonies were large ones. Namely, it was previously 
demonstrated that the size of  colonies is positively correlated with the primitive nature 
of  colony forming cells [23]. Formation of  large CFU-F and a fact that expansion 
was 370 folds for 9 days, support the view that SF of  young adult dogs contains 
mesenchymal progenitors interesting for further investigations. 
We also demonstrated that during a two and three week differentiation period, clusters 
of  differentiated adipocytes and osteoblasts formed. The cells that generated these 
clusters possibly were committed mesenchymal progenitors. Generally, in our culture 
system adipogenesis was weakly induced, but this was also previously observed during 
induction of  adipogenesis in canine adipose tissue MSCs, possibly due to the type of  
medium used [24]. On the other hand, according to hierarchical model of  in vivo and 
in vitro bone marrow mesenchymal progenitor differentiation, adipogenic potential is 
the fi rst to be lost and osteogenic is the last [25]. In our culture system SF cells had a 
weak AP activity and deposition of  calcium salts was scarce comparing to our previous 
experience with dental pulp stem cells indicating that SF contains less unipotent, or 
multipotent mesenchymal progenitors [22]. 
Repair of  cartilage is hard to achieve [26,27]. Until present SF fl uid has been proposed 
as a source of  cells for cartilage cell therapy in humans, rabbits and pigs [3,4,28]. In 
this experiment, expanded canine SF cells were cultivated in chondrogenic medium 
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and after three weeks the pellets contained a cartilage-like tissue. Although cell nuclei 
were scarce, pellets from both, control and chondrogenic medium had abundant ECM 
and specifi c structures (islets) that resembled hyaline cartilage made of  collagen type 
II. No comparable cartilage-like tissue has been described in literature although several 
papers described high chondrogenic potential of  SF cells comparing to adipose tissue 
and bone marrow [11,29]. Interestingly, synovial fl uid progenitors expressing CD90+ 
from normal but not osteoarthritic joints undergo chondrogenic differentiation 
without micro-mass culture [17].
Also, the level of  GAG was two times higher compared to previous data obtained with 
dental pulp stem cells (DPSC) [22]. These fi ndings together with data that primary 
synovial chondromatosis nodules contained cells that spontaneously differentiated 
along chondrogenic and osteogenic lineages [30] and that the gene expression profi les 
of  chondrogenic progenitor cells and synovial cells are closely related [31] indicate that 
SM and SF contain cells that could be designated as mesenchymal chondro-osteogenic 
or chondrogenic progenitors. 
CONCLUSION
Investigations on therapeutic potential of  mesenchymal stem/progenitor cells are on 
the top of  scientifi c objectives worldwide in the last ten years. While abundant data 
were published on chondrogenic/osteogenic potential of  bone marrow and adipose 
tissue MSCs, SF MSCs have not been largely evaluated in spite of  the ease of  access 
and reasonable believe that they possess high chondrogenic potential that could meet 
the clinical needs for the regeneration of  cartilage defects. In this work we have shown 
that dog SF contains cells with a large proliferative potential and important potential 
for chondrogenesis for the fi rst time demonstrated by the formation of  distinct 
pure collagen type II islets in cell pellets. In parallel, only few cells demonstrated 
osteogenic and adipogenic potential that suggests that the majority of  SF cells possess 
chondrogenic potential interesting for further cartilage tissue engineering.
Acknowledgment: 
This work was supported by the grant number 175061 from Ministry of  Education, 
Science and Technologic Development, Republic of  Serbia, Bilateral Serbian-French 
Co-operation “Pavle Savić” for 2012-2013, Short Term Scientifi c Mission COST 
Action MP1005 - NAMABIO and ANR Tecsan “Chondrograft”.
REFERENCES
1. Smith MD: The normal synovium. Open Rheumatol J 2011, 5:100-6.
2. Hunziker EB, Rosenberg LC: Repair of  partial-thickness defects in articular cartilage: cell 
recruitment from the synovial membrane. J Bone Joint Surg Am 1996, 78(5):721-33.
Acta Veterinaria-Beograd 2015, 65 (1), 66-78
76
3. Hunziker EB, Kapfi nger E: Removal of  proteoglycans from the surface of  defects in 
articular cartilage transiently enhances coverage by repair cells. J Bone Joint Surg Br 1998, 
80(1):144-50.
4. Hatsushika D, Muneta T, Nakamura T, Horie M, Koga H, Nakagawa Y, Tsuji K, Hishikawa 
S, Kobayashi E, Sekiya I: Repetitive allogeneic intraarticular injections of  synovial 
mesenchymal stem cells promote meniscus regeneration in a porcine massive meniscus 
defect model. Osteoarthritis Cartilage 2014, 22(7):941-50.
5. Horie M, Driscoll MD, Sampson HW, Sekiya I, Caroom CT, Prockop DJ, Thomas DB: 
Implantation of  allogenic synovial stem cells promotes meniscal regeneration in a rabbit 
meniscal defect model. J Bone Joint Surg Am 2012, 94(8):701-12.
6. Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, Murakami T, Kobayashi 
E: Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and 
promote meniscal regeneration without mobilization to distant organs in rat massive 
meniscal defect. Stem Cells 2009, 27(4):878-87.
7. Furuzawa-Carballeda J, Macip-Rodríguez PM, Cabral AR: Osteoarthritis and rheumatoid 
arthritis pannus have similar qualitative metabolic characteristics and pro-infl ammatory 
cytokine response. Clin Exp Rheumatol 2008, 26(4):554-60.
8. Karystinou A, Dell’Accio F, Kurth TB, Wackerhage H, Khan IM, Archer CW, Jones EA, 
Mitsiadis TA, De Bari C: Distinct mesenchymal progenitor cell subsets in the adult human 
synovium. Rheumatology (Oxford) 2009, 48(9):1057-64.
9. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A, Sekiya I: 
Increased proliferation of  human synovial mesenchymal stem cells with autologous human 
serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine 
serum. Arthritis Rheum 2008;58(2):501-10.
10. Harvanová D1, Tóthová T, Sarišský M, Amrichová J, Rosocha J: Isolation and 
characterization of  synovial mesenchymal stem cells. Folia Biol (Praha) 2011;57(3):119-24.
11. Ando W, Kutcher JJ, Krawetz R, Sen A, Nakamura N, Frank CB, Hart DA: Clonal analysis 
of  synovial fl uid stem cells to characterize and identify stable mesenchymal stromal cell/
mesenchymal progenitor cell phenotypes in a porcine model: a cell source with enhanced 
commitment to the chondrogenic lineage. Cytotherapy 2014, 16(6):776-88. 
12. Morito T, Muneta T, Hara K, Ju YJ, Mochizuki T, Makino H, Umezawa A, Sekiya I: 
Synovial fl uid-derived mesenchymal stem cells increase after intra-articular ligament injury 
in humans. Rheumatology (Oxford) 2008, 47(8):1137-43.
13. Berg RI, Sykes JE, Kass PH, Vernau W: Effect of  repeated arthrocentesis on cytologic 
analysis of  synovial fl uid in dogs. J Vet Intern Med 2009, 23(4):814-7.
14. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of  deep 
cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 
1994, 331(14):889-95.
15. Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP: The OARSI histopathology 
initiative - recommendations for histological assessments of  osteoarthritis in the dog. 
Osteoarthritis Cartilage 2010, 18:S66-79.
16. Portron S, Merceron C, Gauthier O, Lesoeur J, Sourice S, Masson M, Fellah BH, Geffroy 
O, Lallemand E, Weiss P, Guicheux J, Vinatier C: Effects of  in vitro low oxygen tension 
preconditioning of  adipose stromal cells on their in vivo chondrogenic potential: application 
in cartilage tissue repair. PLoS One 2013, 8(4):e62368.
17. Krawetz RJ, Wu YE, Martin L, Rattner JB, Matyas JR, Hart DA: Synovial fl uid progenitors 
expressing CD90+ from normal but not osteoarthritic joints undergo chondrogenic 
differentiation without micro-mass culture. PLoS One 2012,7(8):e43616.
Francuski et al.: Proliferation and differentiation potential of  canine synovial fl uid cells
77
18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, 
Keating A, Prockop Dj, Horwitz E: Minimal criteria for defi ning multipotent mesenchymal 
stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 
2006, 8:315-7.
19. Bianco P, Robey P, Saggio I, Riminucci M: Mesenchymal stem cells in human bone marrow 
(skeletal stem cells): a critical discussion of  their nature, identity, and signifi cance in 
incurable skeletal disease. Human Gene Therapy, 2010, 21:1057-1066.
20. Kovačević Filipović M: The Blood is Rich in Different Types of  Mesoderm Derived Stem 
and Progenitor Cells. Acta veterinaria(Beograd) 2014, 64:156-178.
21. Neidhart M, Seemayer CA, Hummel KM, Michel BA, Gay RE, Gay S: Functional 
characterization of  adherent synovial fl uid cells in rheumatoid arthritis: destructive potential 
in vitro and in vivo. Arthritis Rheum 2003;48(7):1873-80.
22. Debeljak Martačić J, Francuski J, Lužajić T, Vuković N, Mojsilović S, Drndarević N, 
Petakov M, Glibetić M, Marković D, Radovanović A, Todorović V, Kovačević Filipović M: 
Characterization of  deciduous teeth stem cells isolated from crown dental pulp. Vojnosanit 
Pregl 2014, 71:1-10.
23. Ivanović Z, Bartolozzi B, Bernabei PA, Cipolleschi MG, Milenkovic P, Praloran V, 
DelloSbarba P: A simple, one-step clonal assay allows the sequential detection of  
committed (CFU-GM-like) progenitors and several subsets of  primitive (HPP-CFC) 
murine progenitors. Stem Cells 1999,17(4):219-25.
24. Martinello T, Bronzini I, Maccatrozzo L, Mollo A, Sampaolesi M, Mascarello F, Decaminada 
M, Patruno M: Canine adipose-derived-mesenchymal stem cells do not lose stem features 
after a long-term cryopreservation. Res Vet Sci 2011, 91:18-24.
25. Muraglia A, Cancedda R, Quarto R: Clonal mesenchymal progenitors from human bone 
marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000, 113 (Pt 
7):1161-6.
26. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of  deep 
cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 
1994 331:889-95.
27. Horňák S, Harvanová D, Ledecký V, Hluchý M, Valenčáková-Agyagosová A, Amrichová 
J, Rosocha J, Vaško G, Švihla R, Petrovič V: Reparation of  chondral defects in rabbits 
by autologous and allogenous chondrocytes seeded on collagen/hyaluronan scaffold or 
suspended in fi brin glue. Acta veterinaria (Beograd) 2014, 64:61-72.
28. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, 
Emery P, Hatton P, McGonagle D: Synovial fl uid mesenchymal stem cells in health and 
early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis 
Rheumatology 2008, 58:1731-1740.
29. Ichinose S, Muneta T, Koga H, Segawa Y, Tagami M, Tsuji K, Sekiya I: Morphological 
differences during in vitro chondrogenesis of  bone marrow-, synovium-MSCs, and 
chondrocytes. Lab Invest 2010, 90:210-221. 
30. Crawford A, Frazer A, Lippitt JM, Buttle DJ, Smith T: A case of  chondromatosis indicates 
a synovial stem cell aetiology. Rheumatology (Oxford) 2006, 45(12):1529-33. 
31. Zhou C, Zheng H, Seol D, Yu Y, Martin JA: Gene expression profi les reveal that 
chondrogenic progenitor cells and synovial cells are closely related. J Orthop Res 2014, 
32(8):981-8.
Acta Veterinaria-Beograd 2015, 65 (1), 66-78
78
POTENCIJAL ZA PROLIFERACIJU I DIFERENCIJACIJU ĆELIJA 
SINOVIJALNE TEČNOSTI PASA
FRANCUSKI V Jelena, DEBELJAK MARTAČIĆ Jasmina, RADOVANOVIĆ Anita, 
ANDRIĆ Nenad, SOURICE-PETIT Sophie, GUICHEUX Jerome, MOJSILOVIĆ 
Slavko, KOVAČEVIĆ FILIPOVIĆ Milica
Da bi utvrdili da li sinovijalna tečnost (ST) pasa sadrži ćelije koje imaju karakteristike 
mezenhinskih matičnih ćelija (MMĆ), uzorkovana je ST od 5 mladih pasa (starosti 3.8 
± 0.9 godina). Sve adherentne ćelije uzgajane su 3 nedelje na 370C u vlažnoj atmosferi 
sa 5 % CO2, nakon čega je protočnom citometrijom ispitan njihov imunofenotip. In 
vitro je utvrđeno vreme udvajanja ćelija u kulturi, sposobnost stvaranja kolonija fi bro-
blasta (CFU-F) i potencijal za adipogenezu, osteogenezu i hondrogenezu. U ranim 
pasažama, ćelije iz ST su se duplirale na svakih 31 ± 10 sati, a preračunato je da bi 
se nakon 3 subkultivacije teoretski mogle umnožiti 372 ± 134 puta. CFU-F testom 
je pokazano da 0.55 ± 0.05% ćelija može da formira kolonije. Šezdesetšest posto 
ćelija je eksprimiralo CD90 molekul, dok CD34 nije bio eksprimiran na ispitivanim 
ćelijama. Oil Red O bojenjem pokazano je prisustvo masnih kapi u ćelijama uzgajanim 
u adipogenom medijumu, dok su depoziti soli kalcijuma bojenjem alizarin crvenim 
pokazani u ćelijama gajenim u osteogenom medijumu. Ćelijske pelete uzgajane u hon-
drogenom i kontrolnom medijumu su formirale ekstracelularni matriks bogat glikoza-
minoglikanima (GAGs) koji su pokazani bojenjem alcijan plavim. Nije uočena razlika 
u količini GAGs kod ćelija gajenih u hondrogenom i kontrolnom medijumu. Imuno-
histohemijskim bojenjem pokazano je prisustvo kolagena tipa II u peletema gajenim 
u oba medijuma. Ćelije ST in vitro imaju adipogeni, osteogeni i hondrogeni potencijal 
što ukazuje da u ovoj tečnosti postoje mezenhimalni progenitori. Takođe, ove ćelije 
imaju sponatni hondrogeni potencijal koji dalje treba ispitati zbog moguće primene u 
tkivnom inžinjeringu. 
